Bionano Genomics (BNGO) Notes Payables (2023 - 2025)
Historic Notes Payables for Bionano Genomics (BNGO) over the last 3 years, with Q3 2025 value amounting to $9.8 million.
- Bionano Genomics' Notes Payables fell 3429.41% to $9.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.8 million, marking a year-over-year decrease of 3429.41%. This contributed to the annual value of $20.4 million for FY2024, which is 7082.93% down from last year.
- According to the latest figures from Q3 2025, Bionano Genomics' Notes Payables is $9.8 million, which was down 3429.41% from $11.8 million recorded in Q2 2025.
- Over the past 5 years, Bionano Genomics' Notes Payables peaked at $69.8 million during Q4 2023, and registered a low of $9.8 million during Q3 2025.
- In the last 3 years, Bionano Genomics' Notes Payables had a median value of $17.2 million in 2024 and averaged $23.5 million.
- Its Notes Payables has fluctuated over the past 5 years, first crashed by 7082.93% in 2024, then tumbled by 3429.41% in 2025.
- Bionano Genomics' Notes Payables (Quarter) stood at $69.8 million in 2023, then plummeted by 70.83% to $20.4 million in 2024, then plummeted by 51.75% to $9.8 million in 2025.
- Its last three reported values are $9.8 million in Q3 2025, $11.8 million for Q2 2025, and $13.0 million during Q1 2025.